Showing 588 Results
Get to Know Our Schaeffer-NPC Postdoctoral Fellow in Health Policy, Dr. Ilene Hollin
The National Pharmaceutical Council (NPC) has partnered with Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California to create a post-doctoral, two-year…
An Interview With Donna Cryer, Global Liver Institute, on Assessing the Value of Treatments for Liver Diseases
Donna Cryer, JD, a liver transplant recipient and founder, president and CEO of the Global Liver Institute, is a passionate advocate for patients. Most recently, she has turned her attention to…
Is CER Having an Impact on Health Care Decision-Making?
In a newly published Journal of Comparative Effectiveness Research commentary, NPC Vice President for Health Services Research Kimberly Westrich highlights the sixth year results of NPC’s annual…
Improving the Exchange of Health Care Economic Data
One area of interest to the National Pharmaceutical Council (NPC) and our member biopharmaceutical companies—and an area we’ve focused on for several years—has been the exchange of evidence to inform…
Formulary Restrictions May Result in Short-Term Savings, But Also Suboptimal Patient Care
Formulary benefits are generally designed with the intention of lowering costs, typically by encouraging the increased use of generic medications and restricting the use of brand medications or other…
Medication Management in ACOs: Are They Ready?
Are accountable care organizations (ACOs) prepared to utilize medications to achieve the best patient health outcomes, while meeting their financial and quality benchmarks? A poster presentation, …
NPC’s Dr. Graff on Developing Evidence That Is “Fit for Purpose”
What information do payers feel they need to guide their coverage decisions? Jennifer Graff, PharmD, vice president of comparative effectiveness research at the National Pharmaceutical Council (NPC),…
NPC’s Dr. Dubois to Discuss Value Frameworks & Risk-Sharing at Pharmaceutical Summit
NPC Chief Science Officer Dr. Robert W. Dubois will present “Developing and Using Value-Based Frameworks for Pharmaceuticals and Guiding Standards for How to Implement Such Frameworks Correctly” and…
NPC Looks at ASCO's Updated Value Assessment Framework
While the American Society of Clinical Oncology's value assessment framework is still far from perfect, the organization should be commended for the steps it took to listen to outside stakeholders…
NPC’s Dr. Graff to Discuss What Value Should Look Like at BIO Convention
What should value look like? This is the question Jennifer Graff, PharmD, vice president of comparative effectiveness research at the National Pharmaceutical Council (NPC), and fellow panelists will…
CER Collaborative Offers New Tools and Training for New Challenges
Comparative effectiveness research (CER) can help decision-makers use evidence-based insights to improve health care and outcomes for patients. But do decision-makers have the tools and training they…
It’s Important to Have Many Voices in the Value Conversation
Value means different things to different stakeholders, which is why it’s good to see so many voices engaging in this important discussion. Value assessment has the potential to have a tremendous…
PQA’s Annual Meeting To Discuss Progress Toward Value-Based Goals
This year’s Pharmaceutical Quality Alliance’s Annual Meeting, which the National Pharmaceutical Council is cosponsoring, will gather leaders from all stakeholder communities to discuss the state of…
Budget Impact Analysis: An Acceptable Part of Value Assessments or a Discordant Concept?
Value assessments are an evolving area, yet growing in use as health care stakeholders look for ways to evaluate the value of care that is being provided to patients.
The Third Rail—Why Budget Impact Assessments are Not Measures of Value
The National Pharmaceutical Council’s "Guiding Practices for Patient-Centered Value Assessment" address one particular issue that could have significant unintended consequences: budget impact…
Harnessing Data for the Cancer Moonshot
When Vice President Joe Biden speaks at Health Datapalooza on May 9, it will be an exciting reminder of all of the possibilities that health care data holds in seeking cures for cancer and improving…
Tackling Data Access at Health Datapalooza
NPC is looking forward to a robust conversation at Health Datapalooza about how all stakeholders can access and harness the power of data.
Spreading the Word About a Value Assessment: Dissemination and Utilization Factors to Consider
The National Pharmaceutical Council recently unveiled Guiding Practices for Patient-Centered Value Assessment, which offer comprehensive considerations for the development and application of…
NPC Resources Provide Information on Panel Topics at 2016 Armada Specialty Summit
Will you be attending the 2016 Armada Specialty Pharmacy Summit in Las Vegas from May 2-6? Get prepared for the conversations and meetings on event topics with some helpful background resources,…
Don't Miss NPC at ISPOR's 21st Annual International Meeting!
NPC will host a pre-conference symposium, present on various pressing health policy topics and exhibit at the International Society for Pharmacoeconomics and Outcomes Research’s 21st Annual…